<VariationArchive RecordType="classified" VariationID="8963" VariationName="CPT2, 11-BP DUP, NT997" VariationType="Duplication" Accession="VCV000008963" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-08-24" DateCreated="2013-12-05" MostRecentSubmission="2013-12-05">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="24002" VariationID="8963">
      <GeneList>
        <Gene Symbol="CPT2" FullName="carnitine palmitoyltransferase 2" GeneID="1376" HGNC_ID="HGNC:2330" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>1p32.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="53196824" stop="53214197" display_start="53196824" display_stop="53214197" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="53662100" stop="53679868" display_start="53662100" display_stop="53679868" Strand="+" />
          </Location>
          <OMIM>600650</OMIM>
        </Gene>
      </GeneList>
      <Name>CPT2, 11-BP DUP, NT997</Name>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>1p32</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>11-BP DUP, NT997</Name>
      </OtherNameList>
      <XRefList>
        <XRef Type="Allelic variant" ID="600650.0012" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="CPT2, 11-BP DUP, NT997 AND Carnitine palmitoyl transferase II deficiency, neonatal form" Accession="RCV000009525" Version="4">
        <ClassifiedConditionList TraitSetID="2470">
          <ClassifiedCondition DB="MedGen" ID="C1833518">Carnitine palmitoyl transferase II deficiency, neonatal form</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2016-12-29" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2016-12-29" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-12-05" MostRecentSubmission="2013-12-05">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <CitationText>Gellera, C., Witt, D. R., Verderio, E., Cavadini, P., DiDonato, S., Taroni, F. Molecular study of lethal neonatal carnitine palmitoyltransferase II (CPT II) deficiency. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A168-only, 1992.</CitationText>
        </Citation>
        <Citation Type="general">
          <CitationText>Witt, S. R., Theobald, M., Santa-Maria, M., Packman, S., Townsend, S., Sweetman, L., Goodman, S., Rhead, W., Hoppel, C. Carnitine palmitoyl transferase-type 2 deficiency: two new cases and successful prenatal diagnosis. (Abstract) Am. J. Hum. Genet. 49 (suppl.): A109-only, 1991.</CitationText>
        </Citation>
        <ConditionList>
          <TraitSet ID="2470" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4739" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Carnitine palmitoyltransferase II deficiency, lethal neonatal</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT II DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">CPT2 DEFICIENCY, LETHAL NEONATAL</ElementValue>
                <XRef Type="MIM" ID="608836" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carnitine palmitoyl transferase II deficiency, neonatal form</ElementValue>
                <XRef ID="MONDO:0012136" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Carnitine palmitoyltransferase II (CPT II) deficiency is a disorder of long-chain fatty-acid oxidation. The three clinical presentations are lethal neonatal form, severe infantile hepatocardiomuscular form, and myopathic form (which is usually mild and can manifest from infancy to adulthood). While the former two are severe multisystemic diseases characterized by liver failure with hypoketotic hypoglycemia, cardiomyopathy, seizures, and early death, the latter is characterized by exercise-induced muscle pain and weakness, sometimes associated with myoglobinuria. The myopathic form of CPT II deficiency is the most common disorder of lipid metabolism affecting skeletal muscle and the most frequent cause of hereditary myoglobinuria. Males are more likely to be affected than females.</Attribute>
                <XRef ID="NBK1253" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301431</ID>
                <ID Source="BookShelf">NBK1253</ID>
              </Citation>
              <XRef ID="228308" DB="Orphanet" />
              <XRef ID="C1833518" DB="MedGen" />
              <XRef ID="MONDO:0012136" DB="MONDO" />
              <XRef Type="MIM" ID="608836" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="29743" SubmissionDate="2016-12-29" DateLastUpdated="2013-12-05" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="600650.0012_CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL" title="CPT2, 11-BP DUP, NT997_CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL" />
        <ClinVarAccession Accession="SCV000029743" DateUpdated="2013-12-05" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2016-12-29">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs with lethal neonatal CPT II deficiency (608836) originally reported by Witt et al. (1991), Gellera et al. (1992) identified a heterozygous 11-bp insertion mutation in exon 4 of the CPT2 gene (nucleotides 997-1007). The insertion results in a premature termination signal predicted to truncated the CPT2 protein by approximately 350 amino acids at the C terminus. The unaffected mother carried the insertion mutation, but the father had only wildtype alleles; Gellera et al. (1992) concluded that an additional, unidentified CPT2 mutation was present in the affected sibs. Cultured fibroblasts from the patients showed a 92% reduction in CPT II activity and virtual absence of the protein, indicating that complete CPT2 deficiency is a lethal condition.</Attribute>
              <Citation>
                <CitationText>Witt, S. R., Theobald, M., Santa-Maria, M., Packman, S., Townsend, S., Sweetman, L., Goodman, S., Rhead, W., Hoppel, C. Carnitine palmitoyl transferase-type 2 deficiency: two new cases and successful prenatal diagnosis. (Abstract) Am. J. Hum. Genet. 49 (suppl.): A109-only, 1991.</CitationText>
              </Citation>
              <Citation>
                <CitationText>Gellera, C., Witt, D. R., Verderio, E., Cavadini, P., DiDonato, S., Taroni, F. Molecular study of lethal neonatal carnitine palmitoyltransferase II (CPT II) deficiency. (Abstract) Am. J. Hum. Genet. 51 (suppl.): A168-only, 1992.</CitationText>
              </Citation>
              <XRef DB="OMIM" ID="608836" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CPT2" />
          </GeneList>
          <Name>CPT2, 11-BP DUP, NT997</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">11-BP DUP, NT997</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600650.0012" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="29743" TraitType="Disease" MappingType="Name" MappingValue="CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL" MappingRef="Preferred">
        <MedGen CUI="C1833518" Name="Carnitine palmitoyl transferase II deficiency, neonatal form" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

